Literature DB >> 12598608

Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia.

Stephane Martin1, Jean-Pierre Vincent, Jean Mazella.   

Abstract

Microglia motility plays a crucial role in response to lesion or exocytotoxic damage of the cerebral tissue. We used two in vitro assays, a wound-healing model and a chemotaxis assay, to show that the neuropeptide neurotensin elicited the migration of the human microglial cell line C13NJ by a mechanism dependent on both phosphatidylinositol 3-kinase (PI 3-kinase) and mitogen-activated protein (MAP) kinase pathways. The effect of neurotensin on cell migration was blocked by the neurotensin receptor-3 propeptide, a selective ligand of this receptor. We demonstrate, by using RT-PCR, photoaffinity labeling, and Western blot analysis, that the type I neurotensin receptor-3 was the only known neurotensin receptor expressed in these microglial cells and that its activation led to the phosphorylation of both extracellular signal-regulating kinases 1/2 and Akt. Furthermore, the effect of neurotensin on cell migration was preceded by a profound modification of the F-actin cytoskeleton, particularly by the rapid formation of numerous cell filopodia. Both the motility and the filopodia appearance induced by neurotensin were totally blocked by selective inhibitors of MAP kinases or PI 3-kinase pathways. This demonstrates that the neurotensin receptor-3 is functional and mediates the migratory actions of neurotensin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598608      PMCID: PMC6742286     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Production and Characterization of a Novel Monoclonal Antibody Against Human Sortilin.

Authors:  Fatemeh Ghaemimanesh; Ali Ahmad Bayat; Sepideh Babaei; Gholamreza Ahmadian; Amir-Hassan Zarnani; Mehrdad Behmanesh; Mahmood Jeddi-Tehrani; Hodjattallah Rabbani
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-12

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

Review 3.  Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system.

Authors:  Mette Richner; Maj Ulrichsen; Siri Lander Elmegaard; Ruthe Dieu; Lone Tjener Pallesen; Christian Bjerggaard Vaegter
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Revisiting the structure of the Vps10 domain of human sortilin and its interaction with neurotensin.

Authors:  Esben M Quistgaard; Morten K Grøftehauge; Peder Madsen; Lone T Pallesen; Brian Christensen; Esben S Sørensen; Poul Nissen; Claus M Petersen; Søren S Thirup
Journal:  Protein Sci       Date:  2014-07-22       Impact factor: 6.725

5.  ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex.

Authors:  Mary-Louise Rogers; Sheree Bailey; Dusan Matusica; Ian Nicholson; Hakan Muyderman; Promila C Pagadala; Kenneth E Neet; Heddy Zola; Peter Macardle; Robert A Rush
Journal:  J Neuroimmunol       Date:  2010-06-14       Impact factor: 3.478

6.  IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin.

Authors:  Irene Tsilioni; Arti B Patel; Harry Pantazopoulos; Sabina Berretta; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

7.  Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Authors:  Arti B Patel; Irene Tsilioni; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

8.  Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.

Authors:  Jean Mazella; Olivier Pétrault; Guillaume Lucas; Emmanuel Deval; Sophie Béraud-Dufour; Carine Gandin; Malika El-Yacoubi; Catherine Widmann; Alice Guyon; Eric Chevet; Said Taouji; Grégory Conductier; Alain Corinus; Thierry Coppola; Gabriella Gobbi; Jean-Louis Nahon; Catherine Heurteaux; Marc Borsotto
Journal:  PLoS Biol       Date:  2010-04-13       Impact factor: 8.029

9.  Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.

Authors:  Eva Bernhart; Manfred Kollroser; Gerald Rechberger; Helga Reicher; Akos Heinemann; Petra Schratl; Seth Hallström; Andrea Wintersperger; Christoph Nusshold; Trevor DeVaney; Klaus Zorn-Pauly; Roland Malli; Wolfgang Graier; Ernst Malle; Wolfgang Sattler
Journal:  Proteomics       Date:  2010-01       Impact factor: 3.984

Review 10.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.